It is a business services private limited company based in Bhubaneswar, Orissa, India, established in 2017.
2017 | Bhubaneswar, Orissa, India | ActiveHolyhead Pharmaceuticals Private Limited, a active private limited company, was established on 17 March 2017 in Bhubaneswar, Orissa, India. Engaging in other services within the business services sector, it holds CIN: U74999OR2017PTC026744. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sruti Ranjan Mishra (Director), Shilpa Parag Das (Director), Snigdha Mishra (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D-101, Gymkhana Palm Height Shampur, Ghatikia, Bhubaneswar, Orissa, 751003.
U74999OR2017PTC026744
026744
17 March 2017
₹0.10 M
₹0.10 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Holyhead Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sruti Ranjan Mishra | Director | 17 Mar 2017 | Current |
| Shilpa Parag Das | Director | 17 Mar 2017 | Current |
| Snigdha Mishra | Director | 17 Mar 2017 | Current |
| Puspalata Mishra | Director | 17 Mar 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Holyhead Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 49.03% increase in profit. The company's net worth dipped by a decrease of 6.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Holyhead Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Holyhead Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Holyhead Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Holyhead Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Holyhead Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Holyhead Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack. was completed.
Sruti Ranjan Mishra was appointed as a Director was appointed as a Director on 17 Mar 2017 & has been associated with this company since 8 years 10 months . was recorded as a recent event.
Shilpa Parag Das was appointed as a Director was appointed as a Director on 17 Mar 2017 & has been associated with this company since 8 years 10 months . was recorded as a recent event.
Progress on Snigdha Mishra was appointed as a Director was appointed as a Director on 17 Mar 2017 & has been associated with this company since 8 years 10 months . was documented.
The activity Puspalata Mishra was appointed as a Director was appointed as a Director on 17 Mar 2017 & has been associated with this company since 8 years 10 months . was completed.
The CIN of Holyhead Pharmaceuticals Private Limited is U74999OR2017PTC026744.
Holyhead Pharmaceuticals Private Limited is headquartered at D-101, Gymkhana Palm Height Shampur, Ghatikia, Bhubaneswar, Orissa, 751003.
Holyhead Pharmaceuticals Private Limited was incorporated on 17 March 2017.
The current directors of Holyhead Pharmaceuticals Private Limited are
The primary industry of Holyhead Pharmaceuticals Private Limited is Business Services.
Holyhead Pharmaceuticals Private Limited is unlisted.
The authorized capital of Holyhead Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Holyhead Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX